BIRC5 and lung adenocarcinoma: The overexpression of BIRC5 can lead to cell cycle activation to promote the development of lung adenocarcinoma, while negative regulation can dramatically decrease invasion and metastasis capabilities, suppress proliferation, slow growth, induce vascular pulmonary apoptosis, and reverse pulmonary arterial hypertension [105].